Ultrasound indicators of the prostate, urinary bladder and uroflowmetry parameters in the diagnosis of infravesical obstruction in men with benign prostatic hyperplasia

GG Krivoborodov, NS Efremov, AD Bolotov - Urologiia, 2017 - journals.eco-vector.com
Relevance Benign prostatic hyperplasia (BPH) is one of the most common urologic diseases
of males. In patients who failed drug therapy of lower urinary tract symptoms (LUTS) caused …

TIAM1 signaling drives prostatic budding and branching phenotypes and is a potential therapeutic target for BPH

H Khedmatgozar, S Dutta, M Dominguez, D Latour… - bioRxiv, 2024 - biorxiv.org
Benign prostatic hyperplasia (BPH) is the most prevalent urologic disease in men aged over
50 years. However, the molecular mechanisms that drive BPH pathophysiology remain …

[引用][C] BPH 相关LUTS 的临床特点及其对患者生活质量影响的研究

龙智, 何乐业, 张一川, 孙皓, 石玄言, 何景良, 汤育新… - 中国男科学杂志, 2012

[HTML][HTML] Prostatic zonal parameters and lower urinary tract symptoms as quantified via magnetic resonance imaging

J Moryousef, C Sze, DS Elterman, KC Zorn… - Canadian Urological …, 2023 - ncbi.nlm.nih.gov
METHODS Data were retrospectively collected for 144 patients who underwent MRI
between 2015 and 2017 at a single institution. Prostate volumes were measured on sagittal …

[HTML][HTML] Тадалафил в лечении симптомов со стороны нижних мочевых путей: обзор литературы и существующей клинической практики в России

АВ Говоров, ГР Касян, АО Васильев… - Consilium …, 2014 - cyberleninka.ru
В целом и эректильная дисфункция (ЭД), и симптомы нижних мочевых путей (СНМП),
обусловленные доброкачественной гиперплазией предстательной железы (ДГПЖ) …

Over-the-counter medication availability could augment self-management of male lower urinary tract symptoms

CG Roehrborn, MM Miner, R Sadovsky - Postgraduate medicine, 2018 - Taylor & Francis
In this review, we focus on current trends in the management of male lower urinary tract
symptoms (LUTS), defined here as LUTS, namely, storage, voiding, and post-micturition …

Comparison of uwin score with international prostatic symptom score in patients with lower urinary tract symptoms

K Ramaraju, K Rajan, S Kalyanasundaram… - Journal of Evolution of …, 2016 - go.gale.com
BACKGROUND Benign Prostatic Hyperplasia (BPH) is a common disease causing
bothersome symptoms. The AUA Symptom Index or the identical IPSS is recommended for …

[HTML][HTML] Pathological characteristics of CD40/CD40L and NF-κB proteins related to inflammation in benign prostatic hyperplasia tissue: a retrospective study of 120 …

DH Cao, LR Liu, L Li, Y Fang, P Tang, T Li… - … Journal of Clinical …, 2017 - ncbi.nlm.nih.gov
This paper aims to investigate the pathological characteristics of CD40/CD40L and NF-κB
proteins related to inflammation in benign prostatic hyperplasia (BPH) tissue, as well as the …

Efficacy of Alfuzosin in Male Patients with Moderate Lower Urinary Tract Symptoms: Is Metabolic Syndrome a Factor Affecting the Outcome?

G Sonmez, US Topaloglu, M Keske… - Urology Journal, 2020 - journals.sbmu.ac.ir
Purpose: The present study was designed to compare the efficacy of alfuzosin therapy as an
alpha-blocker in metabolic syndrome (MetS) and non-MetS patients with moderate lower …

Роль микроРНК в качестве молекулярно-биологических маркёров дифференциации доброкачественной гиперплазии и рака предстательной железы

ЗМ Ахохов, РС Исмаилов, МИ Коган - Вестник урологии, 2023 - urovest.ru
Аннотация Диагностика и лечение рака предстательной железы (РПЖ) сопряжены с
уровнем простатического специфического антигена (ПСА). Тем не менее некоторые …